See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Microsoft Corporation (MSFT) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Microsoft Corporation (MSFT) - free report >>
Oracle (ORCL): Last Man Standing In TikTok Bid
Last month President Trump vowed to ban the use of the Chinese social media giant domestically if a US enterprise didn't acquire it in 45-days. The Trump administration is concerned that TikTok (and in turn, the Chinese government) knows too much about its 80 million US users.
There has been a slew of eclectic bidders, including Microsoft (MSFT - Free Report) , Walmart (WMT - Free Report) , Twitter , and Oracle (ORCL - Free Report) .
Beijing's latest export restriction on intellectual property threw a wrench into recent negotiations. This has risen the question of whether TikTok's proprietary algorithm could be included in the deal. Without TikTok's underlying algorithm, the value added to an acquirer diminishes significantly.
I believe the new Chinese restriction frightened away bidders granting Oracle the bid.
The specifics of the arrangement are still unknown. According to those familiar with the deal, Oracle is approaching this as more of a partnership than an acquisition.
Despite the relatively high level of uncertainty associated with the agreement, ORCL is up over 4% in trading today.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>